Roferon-A, Interferon alfa-2a recombinant, Sterile Powder for Injection

Social Media Share Tools

Object Details

Hoffmann-La Roche

Roche Laboratories

Description (Brief): Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis. It was discontinued in October 2007, as new therapies for the diseases it treated were developed.; Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human interferon are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferon, which is harvested and used as the active ingredient in Roferon-A.; Object consists of a sealed white cardboard box with red and black print.
Location: Currently not on view

Physical Description: interferon alfa-2a, recombinant, 18 million iu (drug active ingredients); Diluent for Roferon-A, 3 mL (drug active ingredients)
Measurements: overall: 2 in x 2 9/16 in x 1 5/16 in; 5.08 cm x 6.50875 cm x 3.33375 cm; overall: 2 in x 2 1/2 in x 1 3/8 in; 5.08 cm x 6.35 cm x 3.4925 cm

See more items in: Medicine and Science: Medicine; Health & Medicine; The Antibody Initiative; Biotechnology and Genetics; Recombinant Pharmaceuticals; Science & Mathematics; Antibody Initiative: Monoclonal Antibodies

National Museum of American History

GUID (Link to Original Record): http://n2t.net/ark:/65665/ng49ca746a8-9554-704b-e053-15f76fa0b4fa